Introduction {#s1}
============

Colonic diverticular disease is an important cause of hospital admissions and a costly digestive disorder in Western and industrialized communities \[[@R01], [@R02]\]. The prevalence of diverticulosis increases with age from less than 20% at age 40 to 60% by age 60 \[[@R03]\].

Complications in the form of diverticulitis and diverticular bleeding occur in approximately 10-15% of patients \[[@R04], [@R05]\]. The incidence of diverticulitis increases with age with a mean age of 63 years at presentation \[[@R06]\]. Recent studies have suggested either equal gender distribution or a minor female preponderance \[[@R07]\].

Unlike diverticulitis, which predominantly involves the left colon, the right colon is the source of diverticular bleeding in 50-90% of patients \[[@R08], [@R09]\]. Colonic diverticular bleeding occurs mainly in older patients with comorbid conditions, and the combined morbidity and mortality rates from the disease are approximately 10-20% \[[@R09], [@R10]\].

Gastrointestinal symptoms are common among patients with renal failure, approaching 80% in dialysis patients \[[@R11]\]. Most features of diverticular disease, including presentation, and management, are similar in those with and without renal failure. However, compared to those without renal impairment, the disease may occur at a younger age (less than 40 years) and may be more severe in patients with renal dysfunction \[[@R12]\]. Complications, such as perforation, are associated with a higher mortality rate, and patients may have a higher rate of bleeding resulting from iatrogenic anticoagulation and/or platelet dysfunction \[[@R13]\]. Compelling evidence suggests that treatment of diverticular disease complications in patients with renal disease frequently necessitates longer hospitalization, and invasive interventions including surgery \[[@R14], [@R15]\].

In this study, we examined the association between the baseline glomerular filtration rate (GFR) as a marker of renal function and the outcome of symptomatic diverticular disease in a single center retrospective cohort.

Materials and Methods {#s2}
=====================

Setting {#s2a}
-------

This study was conducted at an urban teaching acute care healthcare facility in northeastern USA. The study was approved by the institutional review board (IRB) of the facility.

Study design and subjects {#s2b}
-------------------------

We retrospectively reviewed records of all patients with a primary diagnosis of diverticulitis or diverticular bleeding treated at our hospital from January 1, 2011 to July 31, 2016. Excluded from the study were patients with incidental diagnosis of diverticular disease. Electronic charts of 2,109 patients admitted to our center with colonic diverticular disease were identified. Of these, 291 patients were found to have confirmed diagnosis of diverticulitis or diverticular bleeding.

Patients were evaluated to determine age, gender, race, medications, comorbidities, baseline GFR (mL/min/1.73 m^2^), presenting complains, length of stay (LOS), computed tomography and colonoscopy reports, presence of colonic perforations or abscesses, blood transfusion requirements, and in-hospital mortality. Based on the revised chronic kidney disease (CKD) classification (KDIGO. Summary of recommendation statements. Kidney Int. 2013;3(Suppl):5) and the revised chronic kidney disease (CKD) classification (American Diabetes Association: Diabetes Care. Vol. 30, Supplement 1, 2007), patients with GFR ≥ 30 mL/min/1.73 m^2^ (CKD stages 1, 2, and 3) were clustered at one side as a control group and those with GFR \< 30 mL/min/1.73 m^2^ (CKD stages 4 and 5) constituted the study population.

Statistical analysis {#s2c}
--------------------

Interval data were tested for fit-to-normality by the D'Agostino-Pearson omnibus normality test. Data which did not distribute normally were subjected to the appropriate non-parametric methods; otherwise parametric methods for group-wise comparisons were used. Normally distributed interval data were expressed as mean ± standard deviation (SD); non-normally distributed interval data were presented as median and interquartile range (IQR). Univariate categorical data were evaluated for significance by using the Chi-squared test or Fisher's exact test as appropriate. Covariates were chosen based on P value of ≥ 4α (0.20) and were included in a binary logistic regression model which considered only significant interactions.

Because of the retrospective nature of the study, the odds ratio (OR) and 95% confidence interval (95% CI) were used as the measure of effect size. All inferences regarding statistical significance were based on a P-value \< 0.05 on a two-sided basis. Analyses were performed using Prism^®^ software (GraphPad Corp., San Diego, CA) or SPSS^®^ version 22.0 (IBM Corp., Armonk, NY).

Results {#s3}
=======

Demographic and baseline characteristics {#s3a}
----------------------------------------

Demographic and baseline characteristics in the study group (severely reduced renal function) and control group (normal to moderately reduced renal function) are illustrated in [Table 1](#T1){ref-type="table"}.

###### Demographic and Baseline Characteristics of Patients With Symptomatic Diverticular Disease

                                Normal to moderately reduced renal function   Severely reduced renal function   P-value
  ----------------------------- --------------------------------------------- --------------------------------- ---------
  Age                           63 ± 3.2 years                                65 ± 3.5 years                    0.61
  Gender                        Males: 124/214 (58%)                          Males: 43/77 (56%)                0.47
  Race                                                                                                          
    Black                       51 (23.8%)                                    26 (33.8%)                        0.39
    White                       141 (65.9%)                                   45 (58.4%)                        
    Others                      22 (10.3%)                                    6 (7.8%)                          
  Comorbidities                                                                                                 
    Hypertension                27                                            33                                0.40
    Diabetes mellitus           18                                            24                                0.38
    CAD                         11                                            12                                0.18
    CHF                         14                                            15                                0.40
    COPD                        27                                            25                                0.35
    Stroke                      4                                             5                                 0.20
    Cirrhosis                   3                                             2                                 0.35
  Medications                                                                                                   
    Immunosuppressive therapy   3                                             4                                 0.65
    Anticoagulants              8                                             10                                0.40

Complicated diverticulitis and transfusion requirement {#s3b}
------------------------------------------------------

Perforations or abscesses complicating diverticulitis developed in 31/136 (23%) of patients with GFR ≥ 30 mL/min/1.73 m^2^, and in 13/26 (50%) of patients with GFR \< 30 mL/min/1.73 m^2^ (OR: 3.4; 95% CI: 1.423 - 8.06; P = 0.0073). Mean age for patients with perforations or abscess was 55 ± 3 years in the GFR ≥ 30 mL/min/1.73 m^2^ group and 65 ± 4 years in GFR \< 30 mL/min/1.73 m^2^ group (P = 0.24). Race differences were not statistically different between the two groups (P = 0.76) ([Table 2](#T2){ref-type="table"}).

###### Characteristics of Patients with Complicated Diverticulitis

             GFR ≥ 30 mL/min/1.73 m^2^   GFR \< 30 mL/min/1.73 m^2^   P-value
  ---------- --------------------------- ---------------------------- --------------------------------------------------------------------
  Age        55 ± 3 years                65 ± 4 years                 0.24
  Gender     Males: 20/31 (65%)          Males: 7/13 (54%)            0.59
  Race                                                                
    Black    5 (16%)                     3 (23%)                      0.95
    White    23 (74%)                    8 (62%)                      
    Others   3 (10%)                     2 (15%)                      
  Total      31/136 (23%)                13/26 (50%)                  Odds ratio: 3.4; 95% confidence interval: 1.423 - 8.06; P = 0.0073

Blood transfusion for diverticular bleeding was required in 11/78 (14%) of patients with GFR ≥ 30 mL/min/1.73 m^2^ and in 22/51 (43%) of patients with GFR \< 30 mL/min/1.73 m^2^ (OR: 4.6; 95% CI: 1.99 - 10.76; P = 0.0004). Among patients who needed transfusion, mean age was 71 ± 3.4 years in GFR ≥ 30 mL/min/1.73 m^2^ group and 71 ± 2.4 years in those with GFR \< 30 mL/min/1.73 m^2^ (P = 0.2). Race differences were not statistically significant between the two groups (P = 0.79) ([Table 3](#T3){ref-type="table"}).

###### Characteristics of Patients With Diverticular Bleeding With Transfusion

             GFR ≥ 30 mL/min/1.73 m^2^   GFR \< 30 mL/min/1.73 m^2^   P-value
  ---------- --------------------------- ---------------------------- --------------------------------------------------------------------
  Age        71 ± 3.4 years              71 ± 2.4 years               0.26
  Gender     Males: 8/11 (73%)           Males: 14/22 (64%)           0.23
  Race                                                                
    Black    3 (27%)                     6 (27%)                      0.25
    White    6 (55%)                     13 (59%)                     
    Others   2 (18%)                     3 (14%)                      
  Total      31/136 (23%)                13/26 (50%)                  Odds ratio: 4.6; 95% confidence interval: 1.99 - 10.76; P = 0.0004

The associated comorbidities and other possible confounders are studies as in [Figure 1](#F1){ref-type="fig"}. It showed the OR and 95% CI for the association of severely reduced renal function (GFR \< 30 mL/min/1.73 m^2^) with occurrence of abscess or perforation ([Fig. 1a](#F1){ref-type="fig"}), and with transfusion requirement ([Fig. 1b](#F1){ref-type="fig"}).

![Forest plots showing the OR and 95% CI for the association of impaired renal function (GFR \< 30 mL/min/1.73 m^2^) with abscess or perforation (a) and with transfusion requirement (b). The univariate OR, ORu, is provided, along with the adjusted OR (ORa) for each of the covariates indicated.](gr-10-015-g001){#F1}

LOS {#s3c}
---

The mean LOS for patients with uncomplicated diverticulitis (localized diverticular inflammation with no associated abscess, fistula, obstruction, or perforation), patients with complicated diverticulitis (diverticular inflammation associated with an abscess, fistula, or perforation), and patients with diverticular bleeding in the GFR ≥ 30 mL/min/1.73 m^2^ group, and the GFR \< 30 mL/min/1.73 m^2^ group are shown in [Table 4](#T4){ref-type="table"}.

###### Length of Stay for the Different Study Groups

                                                          GFR ≥ 30 mL/min/1.73 m^2^   GFR \< 30 mL/min/1.73 m^2^   P-value
  ------------------------------------------------------- --------------------------- ---------------------------- -----------
  Uncomplicated diverticulitis                            2.9 ± 1.9                   5.8 ± 2.7                    \< 0.0001
  Complicated diverticulitis (perforations/abscesses)     6.3 ± 4                     8.5 ± 4.4                    0.0001
  Diverticular bleeding without transfusion requirement   3.1 ± 1.5                   4.5 ± 3.6                    0.03
  Diverticular bleeding with transfusion requirement      8.5 ± 2.5                   9 ± 5                        0.04

Discussion {#s4}
==========

In general, the demographic features of patients with severely reduced kidney function who develop symptomatic diverticular disease are not significantly different from those with normal to moderately impaired renal function. Salamone et al presented similar findings when evaluated patients with end-stage renal disease (ESRD) or renal transplantation and symptomatic diverticular disease \[[@R16]\].

The results of this retrospective cohort study show that the incidence of diverticulitis is higher in elderly population irrespective of the degree of renal impairment. Our observations are consistent with those of previous reports regarding the role of increasing age in diverticulitis. Although a slight increase in the incidence of diverticular disease in younger patients was observed during the last decade \[[@R17]\], Blachut et al reported that colonic diverticular disease is a significant problem in elderly patients, in both females and males \[[@R18]\]. Comparato et al reported that individuals younger than 40 years rarely suffer from diverticulitis, and the incidence increases to 65% in people older than 65 years \[[@R19]\].

Complications from diverticulitis such as perforations and abscesses develop at higher rates in patients with severely reduced kidney function. This is also consistent with results of previous reports. Chang et al reported that patients with ESRD has higher incidence of acute colonic diverticulitis, higher rates of surgical interventions and mortality \[[@R20]\]. Morris et al studied the incidence of perforated diverticulitis and risk factors for death in a UK population. The study found a higher mortality rate in those with pre-existing renal impairment \[[@R21]\]. Wang et al proposed that the immunosuppression status in patients with ESRD together with the alteration in colonic microflora and mucosal barrier disruption are the main mechanisms for gut bacterial translocation \[[@R22]\]. Klarenbeek et al worked to identify patients who might benefit from elective sigmoid resection after a conservatively treated episode of diverticulitis. The study concluded that elective resection of the sigmoid colon might be justified in high-risk patients, including those with chronic renal failure \[[@R23]\].

The incidence of diverticular bleeding in patients with ESRD is known to be similar to that of the general population (except for patients with adult polycystic kidney disease (APKD) on regular dialysis who have a higher incidence of diverticular bleeds) \[[@R24], [@R25]\]. Our study shows that there is a higher rate of blood transfusion requirement and an increased length of hospital stay in patients with severely reduced kidney function than in those with normal to moderate renal dysfunction. A Japanese case-control study by Niikura et al reported an OR of 6.4 for diverticular hemorrhage in patients with chronic kidney failure \[[@R26]\]. Ryota et al identified chronic renal failure as a risk factor for diverticular bleeding \[[@R26]\]. In patients with chronic renal failure, intestinal blood vessels are involved by the generalized systemic arteriosclerosis. Furthermore, the heparin used in dialysis, and platelet dysfunction also represent additional risk factors for diverticular bleeding in this group of patients \[[@R27], [@R28]\].

Our study has some limitations. We have not studied the presence of other confounding factors that may affect the outcome of symptomatic diverticular disease such as patients' lifestyle, dietary habits, and smoking history.

Conclusions {#s4a}
-----------

Symptomatic diverticular disease is predominantly a disease of the elderly population. The results of this study provide valuable information regarding the effect of severely reduced renal function on the outcome of symptomatic diverticular disease. The higher rates of complicated diverticulitis, transfusion requirements for diverticular bleeding, and length of hospital stay in patients with severely reduced kidney function compared to patients with normal to moderately reduced renal function, clarify why this group of patients should be treated carefully.
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